Event Information: GUIRR Webinar: NINDS CREATE Bio Program
Registration is required to join this event. If you have not registered, please do so now.
English : New York Time
Event status:
Not started (Register) Click here to register: http://tinyurl.com/ltx59h9
Date and time:
Friday, November 14, 2014 1:00 pm
Eastern Standard Time (New York, GMT-05:00)
Change time zone Friday, November 14, 2014 10:00 am
Pacific Standard Time (San Francisco, GMT-08:00) Panelist(s) Info:
Eastern Standard Time (New York, GMT-05:00)
Change time zone Friday, November 14, 2014 10:00 am
Pacific Standard Time (San Francisco, GMT-08:00) Panelist(s) Info:
Hao Wang, Ph.D., Program Director, NINDS
Duration:
1 hour
Description:
To facilitate therapeutic discovery and development by the neuroscience community, the NINDS recently redesigned their translational programs, which is a suite of complementary programs to encourage the translation of research discoveries into new treatments for disorders that fall under the NINDS mission.
The NINDS Cooperative Research to Enable and Advance Translational Enterprises for Biotechnology Products and Biologics (CREATE Bio) program is dedicated to biotechnology product- and biologics-based therapies, which broadly include modalities such as peptides, proteins, oligonucleotides, gene therapies, and cell therapies. The program includes two tracks: the Discovery Track supports lead optimization in order to obtain a candidate appropriate for entering the Development Track, and the Development Track supports IND-enabling studies for the candidate, as well as early-phase clinical trials. Dr. Wang will give an overview of the CREATE Bio program and general guidance for applications.
For more information about the CREATE Bio program visit the website:http://www.ninds.nih.gov/funding/areas/translational_research/CREATE-bio.htm
The NINDS Cooperative Research to Enable and Advance Translational Enterprises for Biotechnology Products and Biologics (CREATE Bio) program is dedicated to biotechnology product- and biologics-based therapies, which broadly include modalities such as peptides, proteins, oligonucleotides, gene therapies, and cell therapies. The program includes two tracks: the Discovery Track supports lead optimization in order to obtain a candidate appropriate for entering the Development Track, and the Development Track supports IND-enabling studies for the candidate, as well as early-phase clinical trials. Dr. Wang will give an overview of the CREATE Bio program and general guidance for applications.
For more information about the CREATE Bio program visit the website:http://www.ninds.nih.gov/funding/areas/translational_research/CREATE-bio.htm
News Type: